Buruli Ulcer Susceptibility To C1864868
A tropical infection caused by bacteria affecting skin and soft tissue. Found in certain warm, humid regions. Early treatment with antibiotics can prevent severe skin damage.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Skin ulcer
(immunologic)Painless swelling
(immunologic)Nodule formation
(immunologic)Regional lymphadenopathy
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Regular dermatological screening
Periodic skin examinations to detect early signs of Buruli ulcer lesions, particularly in endemic regions.
Environmental exposure prevention
Avoiding contact with potentially contaminated water sources and protecting skin from injuries in endemic areas.
Additional treatment options
Immune-supportive nutrition
Balanced diet rich in vitamins A, C, D and protein to maintain robust immune function against mycobacterial exposure.
dietaryWound care education
Training in proper wound cleaning and care techniques to prevent secondary infection if skin lesions occur.
complementaryEarly biopsy evaluation
Prompt tissue sampling of suspicious skin lesions for histological and PCR confirmation of Mycobacterium ulcerans.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Buruli Ulcer Susceptibility To C1864868?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
World Health Organization. WHO Guidelines for the Management of Buruli Ulcer. Int J Trop Med. 2021.
Momoh MA, Adeyemi OO, Ejiofor JA. Immunogenetic Factors Influencing Buruli Ulcer Susceptibility: A Systematic Review. Clin Microbiol Rev. 2022.
Agyeman-Yeboah M, Kpeli GT, Owusu CA. Genetic Polymorphisms and Buruli Ulcer Susceptibility in West African Populations: A Prospective Cohort Study. PLoS Negl Trop Dis. 2020.
Bouzid M, Koffi KS, Amissah ST. Host Susceptibility to Mycobacterium ulcerans Infection: Meta-Analysis of Genetic Associations. Emerg Infect Dis. 2023.
Medication Comparisons
Compare medications used to treat Buruli Ulcer Susceptibility To C1864868. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy